Investor Information

Serometrix LLC is a privately held company focused on the efficient discovery and optimization of new and novel compounds that may some day have a major impact in the treatment of disease.

Our proprietary drug discovery capabilities are focused on developing novel compounds derived from human proteins.

These high-risk, high reward programs keep our R&D expertise focused on unmet market opportunities where we have the opportunity to generate first-in-class or best-in-class lead compounds, with significant commercial upside.

If you are an investor interested in learning more about Serometrix, contact investor@serometrix.com